US EMS Protocol Census
County

Muskegon County

Current135 dose entries34 drugs1 documentMuskegon, MIeffective 2026-05-2294% machine-parsed of 135

Muskegon County (Muskegon, MI) carries 34 drugs across 135 dose entries in its current published protocol, effective 2026-05-22.

Drugs and doses34

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
SVT adult 6 mg IV not captured standing pages 112, 128, 129, 408, 409 · source
SVT peds 0.1 mg/kg IV not captured standing pages 112, 128, 129, 408, 409 · source

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 2.5 mg NEB not captured standing pages 17, 18 · source
Anaphylaxis peds 2.5 mg NEB not captured standing pages 17, 18 · source
Crush injury adult 2.5 mg NEB not captured standing pages 34, 410 · source
Crush injury peds 2.5 mg NEB not captured standing pages 34, 410 · source
Other adult 2.5 mg NEB not captured standing page 474 · source
Respiratory distress adult 2.5 mg NEB not captured standing pages 65, 66, 89, 410 · source
Respiratory distress peds 2.5 mg NEB not captured standing pages 65, 66, 89, 410 · source

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 325 mg PO not captured standing pages 117, 413 · source
ACS / chest pain adult 325 mg PO not captured standing pages 117, 413 · source

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 1 mg IV/IO not captured standing pages 110, 125, 126, 414 · source
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 110, 125, 126, 414 · source
Nerve agent exposure adult 2 mg IV/IM not captured standing pages 414, 415, 416, 417, 480, 481 · source
Nerve agent exposure peds 0.05 mg/kg IV/IM not captured standing pages 414, 415, 416, 417, 480, 481 · source

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 1 g IV not captured standing pages 35, 418 · source
Hyperkalemia peds 20 mg/kg IV not captured standing pages 35, 418 · source
Other adult 1 g IV not captured standing pages 43, 418, 419 · source
Other adult 1 g IV/IO not captured standing pages 108, 123, 419 · source
Other peds 20 mg/kg IV not captured standing pages 43, 418, 419 · source
Other peds 20 mg/kg IV/IO not captured standing pages 108, 123, 419 · source

Cefazolin

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 g IV not captured standing pages 37, 420, 421 · source
Other peds 30 mg/kg IV not captured standing pages 37, 420, 421 · source

Ceftriaxone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 g IV not captured standing pages 37, 422, 423 · source
Other peds 50 mg/kg IV not captured standing pages 37, 422, 423 · source

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest peds 0.5 g/kg IV/IO not captured standing pages 123, 425 · source
Hypoglycemia adult 25 g IV not captured standing pages 60, 86, 96, 424, 425 · source
Hypoglycemia peds 0.5 g/kg IV not captured standing pages 60, 86, 96, 424, 425 · source
Other adult 25 g IV not captured standing pages 68, 96, 424, 425 · source
Other peds 0.5 g/kg IV not captured standing pages 68, 96, 424, 425 · source

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Procedural sedation adult 5–10 mg IV/IO not captured standing pages 178, 426 · source

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 50 mg IV/IO/IM not captured standing page 18 · source
Allergic reaction peds 1 mg/kg IV/IO/IM not captured standing page 18 · source
Dystonic reaction adult 50 mg IV not captured standing page 43 · source
Dystonic reaction peds 1 mg/kg IV not captured standing page 43 · source
Nausea / vomiting adult 12.5–25 mg IV/IM not captured standing page 12 · source
Nausea / vomiting peds 1 mg/kg IV/IM not captured standing page 12 · source

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3 mg IM not captured standing pages 16, 17 · source
Anaphylaxis peds 0.15 mg IM not captured standing pages 16, 17 · source
Bradycardia peds 0.01 mg/kg IV/IO not captured standing pages 110, 125, 126, 432 · source
Cardiac arrest adult 1 mg IV/IO not captured standing pages 107, 123, 124, 431 · source
Cardiac arrest peds 0.01 mg/kg IV/IO not captured standing pages 107, 123, 124, 431 · source
Hypotension / shock adult 10–20 mcg IV/IO not captured standing pages 14, 15 · source
Hypotension / shock peds 1 mcg/kg IV/IO not captured standing pages 14, 15 · source
Post-ROSC care adult 10–20 mcg IV/IO not captured standing pages 119, 130, 432 · source
Post-ROSC care peds 1 mcg/kg IV/IO not captured standing pages 119, 130, 432 · source
Respiratory distress adult 0.3 mg IM not captured standing pages 66, 67, 90 · source

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 50–100 mcg IV/IO not captured standing pages 178, 179, 434 · source
Other peds 1 mcg/kg IV/IO not captured standing pages 178, 179, 434 · source
Mild to moderate pain adult 1 mcg/kg IV/IO/IM/IN not captured standing pages 118, 168, 434 · source
Mild to moderate pain peds 1 mcg/kg IV/IO/IM/IN not captured standing pages 118, 168, 434 · source

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 1 mg IM not captured standing pages 60, 68, 87, 95, 435, 436 · source
Hypoglycemia adult 3 mg IN not captured standing pages 60, 68, 87, 95, 435, 436 · source
Hypoglycemia peds 0.5 mg IM not captured standing pages 60, 68, 87, 95, 435, 436 · source

Hydrocortisone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 100 mg IV/IM not captured standing page 20 · source
Adrenal crisis peds 1–2 mg/kg IV/IM not captured standing page 20 · source

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 g IV/IO not captured standing pages 437, 489, 490 · source
Cyanide poisoning peds 70 mg/kg IV/IO not captured standing pages 437, 489, 490 · source

Ibuprofen

IndicationPopulationDoseRouteRepeatStandingSource
Fever adult 400 mg PO not captured standing pages 76, 92, 93, 438, 439 · source
Mild to moderate pain adult 400 mg PO not captured standing pages 165, 439 · source

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 500 mcg NEB not captured standing pages 17, 18 · source
Anaphylaxis peds 500 mcg NEB not captured standing pages 17, 18 · source
Respiratory distress adult 500 mcg NEB not captured standing pages 66, 67, 440 · source
Respiratory distress peds 500 mcg NEB not captured standing pages 66, 67, 440 · source

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Hyperactive delirium adult 4 mg/kg IM not captured standing pages 71, 72, 442 · source
Mild to moderate pain adult 0.2 mg/kg IV/IO not captured standing pages 166, 167, 442 · source
Mild to moderate pain adult 0.5 mg/kg IN not captured standing pages 166, 167, 442 · source
Mild to moderate pain peds 0.2 mg/kg IV/IO not captured standing pages 166, 167, 442 · source
Mild to moderate pain peds 0.5 mg/kg IN not captured standing pages 166, 167, 442 · source
Procedural sedation adult 1.5 mg/kg IV/IO/IN not captured standing pages 178, 179, 442 · source
Procedural sedation peds 1.5 mg/kg IV/IO/IN not captured standing pages 178, 179, 442 · source

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 1 mg/kg IV/IO not captured standing pages 108, 123, 444 · source
Cardiac arrest peds 1 mg/kg IV/IO not captured standing pages 108, 123, 444 · source
Mild to moderate pain adult 20 mg IO not captured standing pages 195, 445 · source
Mild to moderate pain peds 0.5 mg/kg IO not captured standing pages 195, 445 · source
Wide-complex tachycardia adult 1 mg/kg IV not captured standing pages 114, 128, 444 · source
Wide-complex tachycardia peds 1 mg/kg IV not captured standing pages 114, 128, 444 · source

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2 g IV not captured standing pages 67, 446, 447 · source
Eclampsia / pre-eclampsia adult 4 g IV/IO not captured standing pages 68, 82, 446, 447 · source
VF / pulseless VT adult 2 g IV/IO not captured standing pages 108, 114, 447 · source

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 125 mg IV/IO/IM not captured standing pages 20, 448 · source
Adrenal crisis peds 2 mg/kg IV/IO/IM not captured standing pages 20, 448 · source
Anaphylaxis adult 125 mg IV/IO/IM not captured standing pages 19, 448 · source
Anaphylaxis peds 2 mg/kg IV/IO/IM not captured standing pages 19, 448 · source
Respiratory distress adult 125 mg IV/IO/IM not captured standing pages 67, 90, 449 · source
Respiratory distress peds 2 mg/kg IV/IO/IM not captured standing pages 67, 90, 449 · source

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Hyperactive delirium adult 10 mg IM/IN not captured standing pages 71, 72, 450 · source
Other adult 0.1 mg/kg IM/IN not captured standing pages 176, 450, 451 · source
Other peds 0.1 mg/kg IM/IN not captured standing pages 176, 450, 451 · source
Procedural sedation adult 1–5 mg IV/IO/IN not captured standing pages 178, 179, 450, 451 · source
Procedural sedation peds 0.05 mg/kg IV/IO/IN not captured standing pages 178, 179, 450, 451 · source
Seizure adult 10 mg IM not captured standing pages 68, 94, 450, 451 · source
Seizure adult 5 mg IV/IO not captured standing pages 68, 94, 450, 451 · source
Seizure adult 5 mg IV/IO/IM/IN not captured standing pages 69, 95, 450, 451 · source
Seizure peds 0.1 mg/kg IM not captured standing pages 68, 94, 450, 451 · source
Seizure peds 0.1 mg/kg IV/IO/IM/IN not captured standing pages 69, 95, 450, 451 · source

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Opioid overdose adult 2 mg IN not captured standing pages 22, 23 · source
Opioid overdose adult 2 mg IM not captured standing pages 22, 23 · source
Opioid overdose adult 2 mg IV not captured standing page 23 · source
Opioid overdose peds 0.1 mg/kg IN not captured standing pages 22, 23 · source
Opioid overdose peds 0.1 mg/kg IM not captured standing pages 22, 23 · source
Opioid overdose peds 0.1 mg/kg IV not captured standing page 23 · source

Nerve Agent Antidote Kit

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 1 kit IM not captured standing pages 415, 476, 479, 480, 481 · source
Nerve agent exposure adult 1 kit IM not captured standing pages 415, 476, 479, 480, 481 · source
Nerve agent exposure peds 1 kit IM not captured standing pages 415, 476, 479, 480, 481 · source
Nerve agent exposure peds 1 kit IM not captured standing pages 415, 476, 479, 480, 481 · source

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 117, 118, 456 · source
CHF / pulmonary edema adult 0.4 mg SL not captured standing pages 115, 456 · source

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 4 mg ODT not captured standing page 11 · source
Nausea / vomiting adult 4 mg IV/IM not captured standing pages 11, 12 · source
Nausea / vomiting peds 0.1 mg/kg IV/IM not captured standing pages 11, 12 · source
Nausea / vomiting peds 4 mg ODT not captured standing page 11 · source

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult small amounts PO not captured standing pages 60, 86, 96 · source
Hypoglycemia peds small amounts PO not captured standing pages 60, 86, 96 · source

Pralidoxime

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 600 mg IV/IM not captured standing pages 459, 460, 461 · source
Nerve agent exposure peds 600 mg IV/IM not captured standing pages 459, 460, 461 · source

Prednisone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 50 mg PO not captured standing page 20 · source
Adrenal crisis peds 50 mg PO not captured standing page 20 · source
Anaphylaxis adult 50 mg PO not captured standing pages 18, 19 · source
Anaphylaxis peds 50 mg PO not captured standing pages 18, 19 · source
Respiratory distress adult 50 mg PO not captured standing pages 66, 67, 90, 462, 463 · source
Respiratory distress peds 50 mg PO not captured standing pages 66, 67, 90, 462, 463 · source

Racemic Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Stridor peds 0.5 mL NEB not captured standing pages 91, 466 · source

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 100 mEq IV not captured standing pages 35, 464 · source
Hyperkalemia peds 1 mEq/kg IV not captured standing pages 35, 464 · source
Other adult 1 mEq/kg IV/IO not captured standing pages 108, 464, 465 · source
Other adult 1 mEq/kg IV/IO not captured standing pages 108, 465 · source
Other peds 1 mEq/kg IV/IO not captured standing pages 108, 464, 465 · source
Other peds 1 mEq/kg IV/IO not captured standing pages 108, 465 · source
Tricyclic overdose adult 50 mEq IV not captured standing pages 43, 464 · source
Tricyclic overdose peds 1 mEq/kg IV not captured standing pages 43, 464 · source

Tetracaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–2 drop not captured not captured standing pages 44, 46, 467 · source
Other peds 1–2 drop not captured not captured standing pages 44, 46, 467 · source

Tranexamic Acid

IndicationPopulationDoseRouteRepeatStandingSource
Trauma / hemorrhage adult 1 g IV/IO not captured standing pages 55, 468 · source

Verapamil

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 5 mg IV not captured standing pages 113, 469 · source